Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04219254
Title A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors BioInvent International AB
Indications

melanoma

Advanced Solid Tumor

lung non-small cell carcinoma

Therapies

BI-1206 + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.